Approval · Notice of Compliance 12982 · 2012
GAMASTAN S/D: Notice of Compliance 12982
Issued January 30, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12982
- Date
- January 30, 2012
- Company
- Grifols Therapeutics LlcClayton, North Carolina, United States
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Passive Immunizing Agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GAMASTAN S/D | 02230579 | Cancelled Post Market |
Medicinal ingredients
- IMMUNOGLOBULIN (HUMAN) 18 PER